San Jose, CA, United States of America

Steve Nero

This inventor holds 1 USPTO granted patent. Top assignee: Koninklijke Philips Corporation N.v.. Active years: 2003.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Steve Nero - Innovator in Medical Imaging Technology

Introduction

Steve Nero is a prominent inventor based in San Jose, California. He has made significant contributions to the field of medical imaging technology. His innovative work has led to the development of a unique system that enhances imaging capabilities in medical settings.

Latest Patents

Steve Nero holds a patent for a "Method and apparatus for dual mode medical imaging system." This invention includes a system that integrates a CT system and an NM system. The system features an NM bed operatively coupled to the NM system and a CT bed operatively coupled to the CT system. Notably, the CT bed can be coupled to the NM bed when the CT system is used for dual mode imaging. This advancement represents a significant step forward in medical imaging technology.

Career Highlights

Steve Nero is associated with Koninklijke Philips Corporation N.V., a leading company in health technology. His work at Philips has allowed him to focus on innovative solutions that improve patient care and diagnostic accuracy. With a total of 1 patent, he has established himself as a valuable contributor to the field.

Collaborations

Steve has collaborated with notable colleagues, including Moataz Karmalawy and Mel Deane. Their combined expertise has fostered an environment of innovation and creativity within their projects.

Conclusion

Steve Nero's contributions to medical imaging technology exemplify the impact of innovation in healthcare. His work continues to influence advancements in the field, ultimately benefiting patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…